miR-342 overexpression results in a synthetic lethal phenotype in <i>BRCA1</i>-mutant HCC1937 breast cancer cells

Elisabetta Crippa(Fondazione IRCCS Istituto Nazionale dei Tumori), Manuela Gariboldi(Fondazione IRCCS Istituto Nazionale dei Tumori)

Oncotarget

February 23, 2016

10.18632/oncotarget.7617

Cited by 23

Related Papers

Metformin transiently inhibits colorectal cancer cell proliferation as a result of either AMPK activation or increased ROS production

|Scientific Reports|2017|130

miR-342 Regulates BRCA1 Expression through Modulation of ID4 in Breast Cancer

|PLoS ONE|2014|66